. Author manuscript; available in PMC: 2014 Sep 16.

Published in final edited form as: Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006627. doi: 10.1002/14651858.CD006627.pub2

Analysis 1.12. Comparison 1 ZIPRASIDONE versus AMISULPRIDE, Outcome 12 Adverse effects: 5. Weight gain of 7% or more of total body weight.

Review: Ziprasidone versus other atypical antipsychotics for schizophrenia

Comparison: 1 ZIPRASIDONE versus AMISULPRIDE

Outcome: 12 Adverse effects: 5. Weight gain of 7% or more of total body weight